RenovoRx, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €107.31M +74.5% €48.67M +87.1% 45.4% +0.030 pp N/A N/A
    (estimated) €61.49M +68.5% €26.02M +135.4% 42.3% +0.12 pp N/A N/A
    (estimated) €36.50M +710.5% €11.05M -198.8% 30.3% +2.8 pp N/A N/A
    (estimated) €4.50M +314.3% -€11.19M +15.5% -248.5% +6.4 pp N/A N/A
    (estimated) €1.09M +2,830.2% -€9.69M +27.4% -891.3% +200 pp N/A N/A
    €37.09K +∞% -€7.60M -13.9% -20,497.7% -200 pp -€7.86M -11.2% -21,193.0% -210 pp
    €0.00 +NaN% -€8.83M +4.7% N/A -€8.85M +16.4% N/A
    €0.00 +NaN% -€8.43M +37.7% N/A -€7.60M +49.3% N/A
    €0.00 +NaN% -€6.12M +61.8% N/A -€5.09M +67.3% N/A
    €0.00 +NaN% -€3.78M +16.1% N/A -€3.04M +5.3% N/A
    €0.00 -€3.26M N/A -€2.89M N/A

    Notifications